Home - Biotech Newswire
Search
HOME
ABOUT US
ABOUT US
SPECIALIZED CHANNELS
ARTIFICIAL INTELLIGENCE
DISTRIBUTION OPTIONS
REFERENCES
PARTNERS
NEWSROOM
EDITOR SIGN-UP
CONTACT
Request a Demo
The
life science
and biotech PR distribution service
All Biotech News
List of articles in category All Biotech News
Title
Published Date
CYTENA Unveils New Generation of B.SIGHT, a Fully Automated Single-Cell Dispenser for Microorganisms
08/08/2022
U.S. Food and Drug Administration (FDA) Approves FYB201/CIMERLI™* (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis®**
08/03/2022
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
08/01/2022
SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)
07/26/2022
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney
07/26/2022
Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®
07/25/2022
NEOsphere Biotechnologies Closes Financing Round to Discover Therapeutic Protein Degraders Via Expanded Proteomics Platform
07/25/2022
Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing
07/20/2022
Apaxen Appoints Graham K. Dixon as Chairman and Prepares for Clinical Testing of its Lead Inflammasome Inhibitor
07/18/2022
Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab
07/15/2022
ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services
07/12/2022
Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration
07/11/2022
ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio
07/05/2022
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
06/28/2022
Richard Wales, Ph.D., and Neil Bargh of Sartorius Honored as Recipients of 2022 ESACT Innovation Award for the Development of the Sartorius Ambr® Technology
06/28/2022
ICPO Foundation Presents its first Maurits W. Geerlings Actinium-225 Next Generation Award to Dr. Madhav Yadav from AIIMS, India at the 6th Theranostics World Congress (TWC)
06/28/2022
Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001
06/27/2022
ProtonDx New Rapid Multi-Viral Pathogen Detection System Receives CE-IVD Mark
06/21/2022
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio
06/15/2022
ValenzaBio Engages ProBioGen For a Second Service Project
06/14/2022
PEPperPRINT GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity
06/09/2022
Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More
06/08/2022
CYTENA Enters Long Term OEM Supply Agreement with PAIA and Launches the F.QUANT Titer, High-Throughput Titer Quantification Assays for Antibodies and Fc Fusion Proteins
06/07/2022
Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich
06/03/2022
ProBioGen Grows by 50 Percent in Last Two Years
06/02/2022
4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease
06/02/2022
Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64
06/02/2022
Vetter Publishes First Sustainability Report
06/01/2022
Samanta Cimitan Appointed Chief Business Officer at Celonic
06/01/2022
Data from SOTIO’s Phase 1/1b AURELIO-03 Trial of SOT101 Demonstrate Clinical Benefit in Patients with Solid Tumors
05/27/2022
Page 6 of 79
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok